Platelet transfusion reactions: Febrile nonhemolytic reaction or bacterial contamination? Diagnosis, detection, and current preventive modalities

Journal of Cardiothoracic and Vascular Anesthesia

Volumn 14, Issue 4, 2000, Pages 460-466

  Sharma, Ajeet D ^a   Grocott, Hilary P ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Bacteria; Cardiac surgery; Platelets; Transfusion reaction

Indexed keywords

BACTERIUM CONTAMINATION; BACTERIUM DETECTION; BLOOD DONOR; BLOOD TRANSFUSION REACTION; DIAGNOSTIC PROCEDURE; DIFFERENTIAL DIAGNOSIS; HEART SURGERY; HEMOLYSIS; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; THROMBOCYTE FUNCTION; THROMBOCYTE TRANSFUSION;

EID: 0033894110     PISSN: 10530770     EISSN: None     Source Type: Journal    
DOI: 10.1053/jcan.2000.7962     Document Type: Article

References (52)

1. Coronary artery bypass grafting: The Society of Thoracic Surgeons National Database experience
2. Hemostatic defects associated with cardiac surgery, prosthetic devices, and other extracorporeal circuits
3. Hematologic changes during and after cardiopulmonary bypass and their relationship to the bleeding time and nonsurgical blood loss
4. Collection and transfusion of blood and blood components in the United States
5. Febrile reactions after platelet transfusion: The effect of single versus multiple donors
6. Evaluation of platelet concentrates prepared from buffy coats and stored in glucose-free crystalloid medium
7. Clinical significance of white cell antibodies in febrile nonhemolytic transfusion reaction
8. Limited efficacy of leukopoor platelets for prevention of febrile transfusion reactions
9. Reaction to platelet transfusions: The effect of the storage time of the concentrate
10. The role of plasma from platelet concentrates in transfusion reactions
11. Increased tumor necrosis factor α (TNFα), interleukin 1, and interleukin 6 (IL-6) levels in plasma of stored platelet concentrates: Relationship between TNFα and IL-6 levels in febrile transfusion reactions
12. Cytokine generation in stored platelet concentrates
13. Effect of prestorage leukocyte removal on the cytokine levels in stored platelet concentrates
14. Septic reactions to platelet transfusions: A persistent problem
15. A prospective study of symptomatic bacteremia following platelet transfusion and its management
16. Blood product-associated bacterial sepsis
17. Bacteria in blood for transfusion
18. Update: Yersinia enterocolitica bacteremia and endotoxin shock associated with red cell transfusion United States
19. Transfusion reactions due to bacterial contamination of blood and blood products
20. Approaches to the detection of bacterial contamination in cellular blood products
21. Bacterial surveillance of platelet concentrates: A comparison of day 1 versus day 3 bacterial cultures
22. Evaluation of an automated microbiologic blood culture device for detection of bacteria in platelet components
23. A multicenter evaluation of reproducibility of swirling in platelet concentrates. Biomedical Excellence for Safer Transfusions (BEST) Working Party of the International Society of Blood Transfusion
24. Evaluation of swirling, pH, and glucose tests for the detection of bacterial contamination in platelet concentrates
25. A multicenter inspection of the swirling phenomenon in platelet concentrates prepared in routine practice. Biomedical Excellence for Safer Transfusions (BEST) Working Party of the International Society of Blood Transfusion
26. Rapid identification of bacterially contaminated platelets using reagent strips: Glucose and pH analysis as markers of bacterial metabolism
27. PH changes caused by bacterial growth in contaminated platelets
28. The use of chemiluminescence-linked universal bacterial ribosomal RNA gene probe and blood gas analysis for the rapid detection of bacterial contamination in white cell-reduced and nonreduced platelets
29. Studies of one invasive and two noninvasive methods for detection of bacterial contamination of platelets
30. Direct identification of Yersinia enterocolitica in blood by polymerase chain reaction amplification
31. Platelet bacterial contamination and rise of a chemiluminescence-linked universal bacterial ribosomal RNA probe
32. Growth and endotoxin production of Yersinia enterocolitica and Enterobacter agglomerans in packed erythrocytes
33. Vancomycin-linked probes and microvolume fluorimetry for rapid detection of gram positive bacterial contamination in platelet products
34. Septic reactions to platelet transfusions: A persistent problem
35. Leukocyte depletion of blood cardioplegia attenuates reperfusion injury
36. Modifying risk for extracorporeal circulation: Trial of four antiinflammatory strategies
37. Bedside filtration of blood products in the prevention of HLA alloimmunization - A prospective randomized study
38. The expression of P-selectin during collection, processing, and storage of platelet concentrates: Relationship to loss of in vivo viability
39. Inactivation of viruses, bacteria, protozoa, and leukocytes in platelet concentrates: Current research perspectives
40. Psoralens as photoactive probes of nucleic acid structure and function: Organic chemistry, photochemistry, and biochemistry
41. Photochemical inactivation of viruses and bacteria in platelet concentrates by use of a novel psoralen and long-wavelength ultraviolet light
42. Psoralen-mediated photo decontamination of platelet concentrates: Inactivation of cell-free and cell-associated forms of human immunodeficiency virus and assessment of platelet function in vivo
43. Use of 8-methoxy-psoralen and long wavelength ultraviolet radiation for decontamination of platelet coucentrates
44. Virus inactivation by methylene-blue/light in thrombocyte concentrates
45. Effect of prestorage white cell reduction on bacterial growth in platelet concentrates
46. In vitro assessment of the quality of stored platelet concentrates. The BEST (Biomedical Excellence for Safer Transfusion) Task Force of the International Society of Blood Transfusion
47. In vitro platelet function of S59 photochemically treated platelet concentrates
48. Post-transfusion viability and tolerability of photochemically treated platelet concentrates
49. How should the safety and efficacy of platelet transfusions be assured?
50. Guidelines for blood component therapy: A report by the American Society of Anesthesiologists' Task Force on Blood Component Therapy